| Role |
Name |
Disclosure |
Details |
| Author | Vlada Groysman, MD, Staff Physician, Department of Dermatology, University of Alabama School of Medicine | Nothing to disclose | Details | | Coauthor | Naveed Sami, MD, FAAD, Assistant Professor Department of Dermatology, University of Alabama School of Medicine | Nothing to disclose | Details | | Medical Editor | Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine | Abbott Laboratories Actelion Amgen Astellas Basilea Briston-Myers Squibb Celtic Pharma Centocor Chattem DermiPsor DOV Galderma Genentech Genzyme Graceway Helix BioMedix Medicis Novartis OMP Pfizer PharmaDerm Stiefel Teva UCB Warner Chilcott Peplin Ranbaxy | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine | Nothing to disclose | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Naveed Sami, Coauthor |
The contributor discloses no conflict of interest. |
|